Replies to post #413384 on Anavex Life Sciences Corp (AVXL)

[Hoskuld]

Yes I think we are, too. The company has traded at much higher levels without more data, so I just don't think it can be about data. And we have evidence right here on this board that people are working very, very hard to undermine the credibility of world class talents. I just don't think that more information really moves the needle unless it is dramatically new information (and it can't be because we already know the summary.)

[WolfofMia]

Not before to which part?

Obviously cant submit an NDA without full data analysis, so yes commercialization on hold.

However more institutions buying is very possible with our current data profile.

Also partnership is very possible with our current data profile.

Furthermore, I sure hope shorts dont cover.

Lastly, please tell me what is the reasoning behind "but not before" to each individual point I just made.

Because I can pull up a couple searches of companies which have partnered with less, approved with less, accumulated with less, and lastly shorts were fried extra crispy for less.

Once multiple doubts about the validity of the data are fully resolved, (sorry, but the doubts persist) partnerships are possible, more institutions will buy in, shorts will flee in panic, commercialization will likely occur and the share price will go up, but not before.